-
1دورية أكاديمية
المؤلفون: Leffers, Ninke, Daemen, Toos, Helfrich, Wijnand, Boezen, H. Marike, Cohlen, Ben J., Melief, Cornelis J. M., Nijman, Hans W.
المصدر: Leffers , N , Daemen , T , Helfrich , W , Boezen , H M , Cohlen , B J , Melief , C J M & Nijman , H W 2014 , ' Antigen-specific active immunotherapy for ovarian cancer ' , Cochrane database of systematic reviews (Online) , no. 9 , 007287 . https://doi.org/10.1002/14651858.CD007287.pub3Test
مصطلحات موضوعية: Antibodies, Monoclonal [therapeutic use], CA-125 Antigen [immunology], Clinical Trials, Phase I as Topic, Phase II as Topic, Immunotherapy, Active [methods], Ovarian Neoplasms [immunology, therapy], Randomized Controlled Trials as Topic, Female, Humans, T-CELL RESPONSES, PHASE-I TRIAL, COLONY-STIMULATING FACTOR, PULSED DENDRITIC CELLS, PEPTIDE-BASED VACCINES, HIGH-DOSE CHEMOTHERAPY, EPITHELIAL OVARIAN, IMMUNE-RESPONSE, SOLID TUMORS, CARCINOEMBRYONIC ANTIGEN
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1002/14651858.CD007287.pub3Test
https://hdl.handle.net/11370/412ec392-86a5-4237-98ee-0af1b22782feTest
https://research.rug.nl/en/publications/412ec392-86a5-4237-98ee-0af1b22782feTest
https://pure.rug.nl/ws/files/67341366/Leffers_et_al_2014_Cochrane_Database_of_Systematic_Reviews.pdfTest -
2دورية أكاديمية
المؤلفون: Nustad, K, Bast, RC, OBrien, TJ, Nilsson, O, Seguin, P, Suresh, MR, Saga, T, Nozawa, S, Bormer, OP, deBruijn, HWA, Vitali, A, Gadnell, M, Clark, J, Shigemasa, K, Karlsson, B, Kreutz, FT, Jette, D, Sakahara, H, Endo, K, Paus, E, Warren, D, Hammarstrom, S, Kenemans, P, Hilgers, J
المصدر: Nustad , K , Bast , RC , OBrien , TJ , Nilsson , O , Seguin , P , Suresh , MR , Saga , T , Nozawa , S , Bormer , OP , deBruijn , HWA , Vitali , A , Gadnell , M , Clark , J , Shigemasa , K , Karlsson , B , Kreutz , FT , Jette , D , Sakahara , H , Endo , K , Paus , E , Warren , D , Hammarstrom , S , Kenemans , P & Hilgers , J 1996 , ' Specificity ....
مصطلحات موضوعية: CA 125 antigen, antibodies, monoclonal, antibody affinity, antibody specificity, epitope mapping, tumor marker, OVARIAN-CANCER, CARCINOEMBRYONIC ANTIGEN, IMMUNORADIOMETRIC ASSAY, MARKER CA-125, CELL-LINE, CA125-ANTIGEN, GLYCOPROTEIN, DETERMINANT, REACTIVITY, CARCINOMAS